These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Association of matrix metalloproteinases' polymorphisms of MMP3 and MMP9 with development of genital endometriosis]. Iarmolinskaia MI; Molotkov AS; Bezhenar' VF; Shved NIu; Ivashchenko TE; Baranov VS Genetika; 2014 Feb; 50(2):230-5. PubMed ID: 25711032 [TBL] [Abstract][Full Text] [Related]
23. Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study. Liu JW; Chen DQ Kaohsiung J Med Sci; 2018 Nov; 34(11):634-642. PubMed ID: 30392570 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of matrix metalloproteinase-1, -2, -3, -7, and -13 gene polymorphisms in patients with chronic periodontitis and healthy controls. Saremi L; Esmaeili S; Ghaffari ME; Shahbazi S; Lotfipanah S; Kadkhodazadeh M Clin Oral Investig; 2023 Dec; 27(12):7417-7423. PubMed ID: 37848583 [TBL] [Abstract][Full Text] [Related]
25. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population. Xu X; Wang L; Xu C; Zhang P; Yong F; Liu H; Wang J; Shi Y Coron Artery Dis; 2013 Jun; 24(4):259-65. PubMed ID: 23377317 [TBL] [Abstract][Full Text] [Related]
26. Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients. Ramezani S; Ezzatifar F; Hojjatipour T; Hemmatzadeh M; Shabgah AG; Navashenaq JG; Aslani S; Shomali N; Arabi M; Babaie F; Jadidi-Niaragh F; Hosseinzadeh R; Feizisani F; Khodayar S; Safari R; Mohammadi H Mol Biol Rep; 2023 Jan; 50(1):173-183. PubMed ID: 36319784 [TBL] [Abstract][Full Text] [Related]
27. [Study on association between single nucleotide polymorphisms of MMP7, MMP8, MMP9 genes and development of gastric cancer and lymph node metastasis]. Kim JH; Pyun JA; Lee KJ; Cho SW; Kwack KB Korean J Gastroenterol; 2011 Nov; 58(5):245-51. PubMed ID: 22113040 [TBL] [Abstract][Full Text] [Related]
28. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721 [TBL] [Abstract][Full Text] [Related]
30. [Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women]. Shevchenko AV; Konenkov VI; Garbukov EIu; Stakheeva MN Vopr Onkol; 2014; 60(5):630-5. PubMed ID: 25816670 [TBL] [Abstract][Full Text] [Related]
32. Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis. Yan Y; Fang L; Li Y; Yu Y; Li Y; Cheng JC; Sun YP Gene; 2021 Jan; 767():145173. PubMed ID: 33007375 [TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955 [TBL] [Abstract][Full Text] [Related]
34. MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Singh H; Jain M; Mittal B Gynecol Oncol; 2008 Jul; 110(1):71-5. PubMed ID: 18448157 [TBL] [Abstract][Full Text] [Related]
35. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933 [TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study. Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607 [TBL] [Abstract][Full Text] [Related]
37. The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. Pérez-Hernández N; Vargas-Alarcón G; Martínez-Rodríguez N; Martínez-Ríos MA; Peña-Duque MA; Peña-Díaz Ade L; Valente-Acosta B; Posadas-Romero C; Medina A; Rodríguez-Pérez JM J Atheroscler Thromb; 2012; 19(8):718-27. PubMed ID: 22785600 [TBL] [Abstract][Full Text] [Related]
38. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer]. Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692 [TBL] [Abstract][Full Text] [Related]
39. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India. Srivastava P; Kapoor R; Mittal RD Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671 [TBL] [Abstract][Full Text] [Related]
40. Genetic susceptibility to periapical disease: conditional contribution of MMP2 and MMP3 genes to the development of periapical lesions and healing response. Menezes-Silva R; Khaliq S; Deeley K; Letra A; Vieira AR J Endod; 2012 May; 38(5):604-7. PubMed ID: 22515887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]